|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 113, Issue 12 2149-2155, Copyright © 2000 by Company of Biologists
JOURNAL ARTICLES |
XD Tan, YH Chen, QP Liu, F Gonzalez-Crussi and XL Liu
Department of Pathology, Children's Memorial Hospital, Northwestern University, Chicago, IL 60614, USA. xtan@nwu.edu
Trefoil factors are small peptides found in several mammalian tissues including gut, respiratory tract and brain. Their physiological function is not well understood. Among them, trefoil factor 3 (intestinal trefoil factor) is known to be cytoprotective in the gut. However, the molecular mechanism and secondary mediators of trefoil factor 3 action are not known. In the present study, we examined whether the cyclooxygenase pathway is involved in trefoil factor 3 action. We showed that trefoil factor 3 significantly induces the production of prostaglandin E(2) and prostaglandin I(2) in IEC-18 cells (an intestinal epithelial cell line) in a dose dependent manner. Western blot and immunohistochemistry revealed that trefoil factor 3 (2.5 microM) up-regulates the expression of cyclooxygenase-2 but not cyclooxygenase-1 in IEC-18 cells. Treating cells with trefoil factor 3 (10 microM) significantly attenuated reactive oxygen species-induced IEC-18 cell injury. This effect is blocked by NS-398 (10 microM), a selective cyclooxygenase-2 inhibitor. Moreover, we demonstrated that exogenously administered carbacyclin (1 microM, a stable analogue of prostaglandin I(2)) and/or prostaglandin E(2) (1 microM) caused a significant reduction of reactive oxygen species-induced cell injury, mimicking the effect of trefoil factor 3. In summary, our results indicate that trefoil factor 3 activates cyclooxygenase-2 in intestinal epithelium to produce prostaglandin I(2) and prostaglandin E(2), which function as survival factors and mediate the cytoprotective action of trefoil factor 3 against oxidant injury.
This article has been cited by other articles:
|
|
 |
|
  H.-F. Bu, X. Wang, Y.-Q. Zhu, R. Y. Williams, W. Hsueh, X. Zheng, R. A. Rozenfeld, X.-L. Zuo, and X.-D. Tan Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity J. Immunol., December 15, 2006; 177(12): 8767 - 8776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. STEIDLER and P. ROTTIERS Therapeutic Drug Delivery by Genetically Modified Lactococcus lactis. Ann. N.Y. Acad. Sci., August 1, 2006; 1072: 176 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Q. Zhu and X.-D. Tan TFF3 modulates NF-{kappa}B and a novel negative regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha} Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1085 - C1093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Liu, A. Stromberg, H.-H. Tai, and J. A. Moscow Thiamine Transporter Gene Expression and Exogenous Thiamine Modulate the Expression of Genes Involved in Drug and Prostaglandin Metabolism in Breast Cancer Cells Mol. Cancer Res., August 1, 2004; 2(8): 477 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Q. Zhu, Y. Lu, and X.-D. Tan Monochloramine induces reorganization of nuclear speckles and phosphorylation of SRp30 in human colonic epithelial cells: role of protein kinase C Am J Physiol Cell Physiol, November 1, 2003; 285(5): C1294 - C1303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Fernandez-Estivariz, L. H. Gu, L. Gu, C. R. Jonas, T. M. Wallace, R. R. Pascal, K. L. Devaney, C. L. Farrell, D. P. Jones, D. K. Podolsky, et al. Trefoil peptide expression and goblet cell number in rat intestine: effects of KGF and fasting-refeeding Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2003; 284(2): R564 - R573. [Abstract] [Full Text] [PDF]
|
|
